| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701925 | Journal of Thoracic Oncology | 2017 | 9 Pages |
Abstract
The proportion of untreated patients with stage IIIA and IV disease is increasing. Survival outcomes among patients with advanced-stage disease are superior with treatment, independent of selection bias. The benefits and risks of treatment should be carefully assessed before choosing to forego treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Elizabeth A. MD, Megan E. MD, Chin-Shang PhD, Chi-Lu MS, David T. MD, Lisa M. MD, MAS, Joy MD, MPH, Karen MD, Robert J. MD, MAS,